Revamp Medical this week announced it appointed Mike Favet as CEO, effective immediately. Favet joins the Netanya, Israel–based heart failure congestion management company with more than 20 years of executive-level experience. He most recently was CEO of Neuropace, where he led a commercial expansion and took the company public in 2021. “Mike brings a distinguished […]
Revamp Medical
The top 10 catheter innovations of 2020
As the COVID-19 pandemic took over the world in 2020, medical device companies continued to showcase new catheter innovations. Throughout 2020, we saw FDA clearances, approvals and product launches for a variety of catheter-based technologies, including renal denervation systems, heart failure treatment catheters, mechanical thrombectomy systems and more. The list includes some medtech giants like […]
Revamp Medical acute heart failure catheter wins FDA breakthrough device designation
Revamp Medical this week said its Doraya acute heart failure catheter received FDA breakthrough device designation. Doraya is a temporary intravenous catheter that is placed in the inferior vena cava below the renal veins. It applies partial adjustable flow for up to 12 hours. Get the full story on our sister site, Medical Tubing + […]
